

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protoporphyrinogen IX metabolic process (GO:0046501) | 5.75167716 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.45917075 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.45917075 |
| 4 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 5.44998558 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 5.39449451 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.39449451 |
| 7 | lysine catabolic process (GO:0006554) | 5.15428260 |
| 8 | lysine metabolic process (GO:0006553) | 5.15428260 |
| 9 | cysteine metabolic process (GO:0006534) | 5.02117268 |
| 10 | aromatic amino acid family catabolic process (GO:0009074) | 4.96727007 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.89400958 |
| 12 | positive regulation of histone deacetylation (GO:0031065) | 4.81449922 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 4.55085582 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 4.55085582 |
| 15 | tryptophan catabolic process (GO:0006569) | 4.55085582 |
| 16 | glyoxylate metabolic process (GO:0046487) | 4.54700102 |
| 17 | heme biosynthetic process (GO:0006783) | 4.52691568 |
| 18 | kynurenine metabolic process (GO:0070189) | 4.49363198 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 4.49143988 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 4.48718501 |
| 21 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 4.45774081 |
| 22 | base-excision repair, AP site formation (GO:0006285) | 4.42916761 |
| 23 | ethanol oxidation (GO:0006069) | 4.39855092 |
| 24 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.29322572 |
| 25 | tryptophan metabolic process (GO:0006568) | 4.26845076 |
| 26 | porphyrin-containing compound biosynthetic process (GO:0006779) | 4.17121423 |
| 27 | heme metabolic process (GO:0042168) | 4.11853732 |
| 28 | glycine metabolic process (GO:0006544) | 4.08854696 |
| 29 | high-density lipoprotein particle remodeling (GO:0034375) | 4.08333980 |
| 30 | pseudouridine synthesis (GO:0001522) | 4.05154025 |
| 31 | bile acid biosynthetic process (GO:0006699) | 4.04805012 |
| 32 | peptidyl-histidine modification (GO:0018202) | 4.04252025 |
| 33 | cellular ketone body metabolic process (GO:0046950) | 4.03753390 |
| 34 | amino-acid betaine metabolic process (GO:0006577) | 3.96333447 |
| 35 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.96288575 |
| 36 | serine family amino acid catabolic process (GO:0009071) | 3.94769633 |
| 37 | S-adenosylmethionine metabolic process (GO:0046500) | 3.93082128 |
| 38 | L-methionine salvage (GO:0071267) | 3.92657878 |
| 39 | L-methionine biosynthetic process (GO:0071265) | 3.92657878 |
| 40 | amino acid salvage (GO:0043102) | 3.92657878 |
| 41 | regulation of triglyceride catabolic process (GO:0010896) | 3.92358716 |
| 42 | negative regulation of fibrinolysis (GO:0051918) | 3.86919928 |
| 43 | tetrapyrrole biosynthetic process (GO:0033014) | 3.85623204 |
| 44 | serine family amino acid metabolic process (GO:0009069) | 3.83459636 |
| 45 | porphyrin-containing compound metabolic process (GO:0006778) | 3.83207397 |
| 46 | DNA deamination (GO:0045006) | 3.79298191 |
| 47 | urea cycle (GO:0000050) | 3.75810985 |
| 48 | urea metabolic process (GO:0019627) | 3.75810985 |
| 49 | serine family amino acid biosynthetic process (GO:0009070) | 3.74184908 |
| 50 | regulation of protein activation cascade (GO:2000257) | 3.73240130 |
| 51 | aromatic amino acid family metabolic process (GO:0009072) | 3.72641871 |
| 52 | valine metabolic process (GO:0006573) | 3.71694499 |
| 53 | protein carboxylation (GO:0018214) | 3.69879466 |
| 54 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.69879466 |
| 55 | GDP-mannose metabolic process (GO:0019673) | 3.69335862 |
| 56 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.68599869 |
| 57 | alpha-amino acid catabolic process (GO:1901606) | 3.67919889 |
| 58 | response to misfolded protein (GO:0051788) | 3.66584084 |
| 59 | regulation of fibrinolysis (GO:0051917) | 3.62634718 |
| 60 | protein-lipid complex remodeling (GO:0034368) | 3.61655767 |
| 61 | macromolecular complex remodeling (GO:0034367) | 3.61655767 |
| 62 | plasma lipoprotein particle remodeling (GO:0034369) | 3.61655767 |
| 63 | methionine biosynthetic process (GO:0009086) | 3.60837337 |
| 64 | homocysteine metabolic process (GO:0050667) | 3.58794433 |
| 65 | reverse cholesterol transport (GO:0043691) | 3.58601537 |
| 66 | aspartate family amino acid catabolic process (GO:0009068) | 3.58418864 |
| 67 | 2-oxoglutarate metabolic process (GO:0006103) | 3.57649845 |
| 68 | fatty acid beta-oxidation (GO:0006635) | 3.56100118 |
| 69 | pyrimidine-containing compound salvage (GO:0008655) | 3.55384666 |
| 70 | pyrimidine nucleoside salvage (GO:0043097) | 3.55384666 |
| 71 | positive regulation of protein deacetylation (GO:0090312) | 3.53680942 |
| 72 | short-chain fatty acid metabolic process (GO:0046459) | 3.53262614 |
| 73 | bile acid metabolic process (GO:0008206) | 3.51880488 |
| 74 | regulation of hippo signaling (GO:0035330) | 3.51023403 |
| 75 | fatty acid oxidation (GO:0019395) | 3.50434670 |
| 76 | heme transport (GO:0015886) | 3.49205432 |
| 77 | nitrogen cycle metabolic process (GO:0071941) | 3.49126756 |
| 78 | plasma lipoprotein particle assembly (GO:0034377) | 3.48833549 |
| 79 | regulation of complement activation (GO:0030449) | 3.48576847 |
| 80 | nucleoside salvage (GO:0043174) | 3.47795960 |
| 81 | ketone body metabolic process (GO:1902224) | 3.45988607 |
| 82 | complement activation, alternative pathway (GO:0006957) | 3.45970142 |
| 83 | cellular amino acid catabolic process (GO:0009063) | 3.45117833 |
| 84 | negative regulation of cholesterol transport (GO:0032375) | 3.44368281 |
| 85 | negative regulation of sterol transport (GO:0032372) | 3.44368281 |
| 86 | acylglycerol homeostasis (GO:0055090) | 3.43091539 |
| 87 | triglyceride homeostasis (GO:0070328) | 3.43091539 |
| 88 | lipid oxidation (GO:0034440) | 3.42163753 |
| 89 | tRNA modification (GO:0006400) | 3.41429433 |
| 90 | regulation of cholesterol esterification (GO:0010872) | 3.41336591 |
| 91 | aldehyde catabolic process (GO:0046185) | 3.39126679 |
| 92 | imidazole-containing compound metabolic process (GO:0052803) | 3.34615502 |
| 93 | bile acid and bile salt transport (GO:0015721) | 3.33012022 |
| 94 | fatty acid catabolic process (GO:0009062) | 3.31018841 |
| 95 | cellular response to ATP (GO:0071318) | 3.30496641 |
| 96 | blood coagulation, intrinsic pathway (GO:0007597) | 3.30429974 |
| 97 | tyrosine metabolic process (GO:0006570) | 3.30216989 |
| 98 | carnitine metabolic process (GO:0009437) | 3.29317717 |
| 99 | plasma lipoprotein particle clearance (GO:0034381) | 3.27018018 |
| 100 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.25925792 |
| 101 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.25925792 |
| 102 | NADH dehydrogenase complex assembly (GO:0010257) | 3.25925792 |
| 103 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 3.25346748 |
| 104 | phospholipid efflux (GO:0033700) | 3.25219973 |
| 105 | response to nitrosative stress (GO:0051409) | 3.24972609 |
| 106 | carboxylic acid catabolic process (GO:0046395) | 3.24136000 |
| 107 | organic acid catabolic process (GO:0016054) | 3.24136000 |
| 108 | branched-chain amino acid catabolic process (GO:0009083) | 3.23852662 |
| 109 | opioid receptor signaling pathway (GO:0038003) | 3.21566825 |
| 110 | monocarboxylic acid catabolic process (GO:0072329) | 3.21313285 |
| 111 | sulfur amino acid biosynthetic process (GO:0000097) | 3.20487620 |
| 112 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.20315480 |
| 113 | cofactor catabolic process (GO:0051187) | 3.20185607 |
| 114 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.20172693 |
| 115 | acetyl-CoA metabolic process (GO:0006084) | 3.19771532 |
| 116 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 3.18995225 |
| 117 | behavioral response to nicotine (GO:0035095) | 3.18657249 |
| 118 | indolalkylamine metabolic process (GO:0006586) | 3.18045873 |
| 119 | ethanol metabolic process (GO:0006067) | 3.16686445 |
| 120 | aspartate family amino acid biosynthetic process (GO:0009067) | 3.15269936 |
| 121 | autophagic vacuole fusion (GO:0000046) | 3.15052664 |
| 122 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.14844211 |
| 123 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.14844211 |
| 124 | folic acid metabolic process (GO:0046655) | 3.14793472 |
| 125 | DNA methylation involved in gamete generation (GO:0043046) | 3.14370397 |
| 126 | drug catabolic process (GO:0042737) | 3.14004164 |
| 127 | amine catabolic process (GO:0009310) | 3.13284772 |
| 128 | cellular biogenic amine catabolic process (GO:0042402) | 3.13284772 |
| 129 | exogenous drug catabolic process (GO:0042738) | 3.13192244 |
| 130 | cellular modified amino acid catabolic process (GO:0042219) | 3.13054813 |
| 131 | NAD biosynthetic process (GO:0009435) | 3.12910778 |
| 132 | benzene-containing compound metabolic process (GO:0042537) | 3.12054496 |
| 133 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.11393304 |
| 134 | mannosylation (GO:0097502) | 3.08120323 |
| 135 | branched-chain amino acid metabolic process (GO:0009081) | 3.07775689 |
| 136 | methionine metabolic process (GO:0006555) | 3.05837191 |
| 137 | cardiolipin metabolic process (GO:0032048) | 3.00941475 |
| 138 | ncRNA 3-end processing (GO:0043628) | 3.00216616 |
| 139 | ubiquinone biosynthetic process (GO:0006744) | 2.90273058 |
| 140 | drug transport (GO:0015893) | 2.89695763 |
| 141 | regulation of histone deacetylation (GO:0031063) | 2.86283259 |
| 142 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.82768206 |
| 143 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.81850943 |
| 144 | piRNA metabolic process (GO:0034587) | 2.81826325 |
| 145 | tRNA methylation (GO:0030488) | 2.81565904 |
| 146 | N-acetylneuraminate metabolic process (GO:0006054) | 2.81176840 |
| 147 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.79283586 |
| 148 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.78247856 |
| 149 | meiotic chromosome segregation (GO:0045132) | 2.76498523 |
| 150 | maturation of 5.8S rRNA (GO:0000460) | 2.75873578 |
| 151 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.74117314 |
| 152 | organic cation transport (GO:0015695) | 2.74053848 |
| 153 | mitochondrial RNA metabolic process (GO:0000959) | 2.72941130 |
| 154 | negative regulation of telomere maintenance (GO:0032205) | 2.72859529 |
| 155 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.69843002 |
| 156 | protein complex biogenesis (GO:0070271) | 2.66487855 |
| 157 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.66338347 |
| 158 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.65913029 |
| 159 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.64444518 |
| 160 | male meiosis I (GO:0007141) | 2.63738870 |
| 161 | metallo-sulfur cluster assembly (GO:0031163) | 2.58376564 |
| 162 | iron-sulfur cluster assembly (GO:0016226) | 2.58376564 |
| 163 | oxidative demethylation (GO:0070989) | 2.57861283 |
| 164 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.55459799 |
| 165 | phenol-containing compound catabolic process (GO:0019336) | 2.54627543 |
| 166 | response to pheromone (GO:0019236) | 2.53226766 |
| 167 | androgen biosynthetic process (GO:0006702) | 2.51975424 |
| 168 | arginine metabolic process (GO:0006525) | 2.51781315 |
| 169 | regulation of histone phosphorylation (GO:0033127) | 2.50784276 |
| 170 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.50739264 |
| 171 | dopamine transport (GO:0015872) | 2.50300271 |
| 172 | proline biosynthetic process (GO:0006561) | 2.49734369 |
| 173 | GTP biosynthetic process (GO:0006183) | 2.48733442 |
| 174 | RNA modification (GO:0009451) | 2.47756234 |
| 175 | UTP biosynthetic process (GO:0006228) | 2.47464555 |
| 176 | organelle membrane fusion (GO:0090174) | 2.46702312 |
| 177 | rRNA modification (GO:0000154) | 2.46444842 |
| 178 | arginine catabolic process (GO:0006527) | 2.46200263 |
| 179 | regulation of triglyceride metabolic process (GO:0090207) | 2.45566601 |
| 180 | tRNA processing (GO:0008033) | 2.41913335 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.43683419 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.88164446 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.63063820 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.46276784 |
| 5 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.98871764 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.90485275 |
| 7 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.89608138 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.70851744 |
| 9 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.42948147 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.07296912 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.99192564 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.86349217 |
| 13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.74386290 |
| 14 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.64084934 |
| 15 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.26153307 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.18066617 |
| 17 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 2.14329418 |
| 18 | P68_20966046_ChIP-Seq_HELA_Human | 2.10322024 |
| 19 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.08384161 |
| 20 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.97489353 |
| 21 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.95248241 |
| 22 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.91086388 |
| 23 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.89767311 |
| 24 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.88616628 |
| 25 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.88452353 |
| 26 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.83741140 |
| 27 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.83322633 |
| 28 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.81703638 |
| 29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.76708295 |
| 30 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.75663480 |
| 31 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.73282685 |
| 32 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.69695063 |
| 33 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.69664245 |
| 34 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.67090645 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.66357424 |
| 36 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.66117379 |
| 37 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.63550730 |
| 38 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.61899099 |
| 39 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.61558416 |
| 40 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.59323808 |
| 41 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.59145578 |
| 42 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.58421673 |
| 43 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.54617777 |
| 44 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.53298887 |
| 45 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.52437234 |
| 46 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51387231 |
| 47 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.47640054 |
| 48 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47237683 |
| 49 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.47005980 |
| 50 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.46689658 |
| 51 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.45871887 |
| 52 | ERA_21632823_ChIP-Seq_H3396_Human | 1.44696627 |
| 53 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.43543030 |
| 54 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.42647501 |
| 55 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.40849465 |
| 56 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.40131513 |
| 57 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.39047621 |
| 58 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.37912385 |
| 59 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.37333073 |
| 60 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.36828588 |
| 61 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.36611217 |
| 62 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.35354894 |
| 63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.34864660 |
| 64 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.34640856 |
| 65 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.33866193 |
| 66 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33359854 |
| 67 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.31412086 |
| 68 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.30084773 |
| 69 | * MYC_22102868_ChIP-Seq_BL_Human | 1.29303786 |
| 70 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.29216616 |
| 71 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.28375578 |
| 72 | P300_27268052_Chip-Seq_Bcells_Human | 1.27532551 |
| 73 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.26604282 |
| 74 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.26535460 |
| 75 | MAF_26560356_Chip-Seq_TH2_Human | 1.26362232 |
| 76 | GATA1_19941826_ChIP-Seq_K562_Human | 1.25184579 |
| 77 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.24413023 |
| 78 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.22597684 |
| 79 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.22155505 |
| 80 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.21964403 |
| 81 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.21685953 |
| 82 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.20634377 |
| 83 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20566567 |
| 84 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.20288079 |
| 85 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.20195370 |
| 86 | SA1_27219007_Chip-Seq_Bcells_Human | 1.20043558 |
| 87 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.19656903 |
| 88 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.19275479 |
| 89 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.18765899 |
| 90 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.18741947 |
| 91 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.17275895 |
| 92 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.17013421 |
| 93 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.16694986 |
| 94 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.15231987 |
| 95 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.12827046 |
| 96 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.12553151 |
| 97 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.11648924 |
| 98 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.10551820 |
| 99 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.09613520 |
| 100 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.09595009 |
| 101 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.09429004 |
| 102 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.09420650 |
| 103 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.08683357 |
| 104 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.07459683 |
| 105 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.06710051 |
| 106 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.06301841 |
| 107 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05194164 |
| 108 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.04991874 |
| 109 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.04240394 |
| 110 | VDR_22108803_ChIP-Seq_LS180_Human | 1.04162898 |
| 111 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.04021565 |
| 112 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.03922376 |
| 113 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03899309 |
| 114 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.03400362 |
| 115 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.02594391 |
| 116 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02028119 |
| 117 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99607828 |
| 118 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.98744006 |
| 119 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.97689402 |
| 120 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.97360746 |
| 121 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.96075456 |
| 122 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95843859 |
| 123 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.94882058 |
| 124 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94869488 |
| 125 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.93809005 |
| 126 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.93287649 |
| 127 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.93077260 |
| 128 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.92912699 |
| 129 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.92815070 |
| 130 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.92720222 |
| 131 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.91502300 |
| 132 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.91097283 |
| 133 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90862670 |
| 134 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.87374300 |
| 135 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.85590275 |
| 136 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85269859 |
| 137 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.84050942 |
| 138 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82894796 |
| 139 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.82548101 |
| 140 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.81968392 |
| 141 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.81777130 |
| 142 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.81360999 |
| 143 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.79972857 |
| 144 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.78900414 |
| 145 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.78474902 |
| 146 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.77917326 |
| 147 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.77529109 |
| 148 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.76754876 |
| 149 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.76296541 |
| 150 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.76241790 |
| 151 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.75980847 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.12870215 |
| 2 | MP0005360_urolithiasis | 5.60384995 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.67462729 |
| 4 | MP0005365_abnormal_bile_salt | 4.57510949 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 4.35712219 |
| 6 | MP0003656_abnormal_erythrocyte_physiolo | 4.23983747 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 4.04716219 |
| 8 | MP0004147_increased_porphyrin_level | 3.53015545 |
| 9 | MP0009840_abnormal_foam_cell | 3.05966533 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.89660733 |
| 11 | MP0003252_abnormal_bile_duct | 2.62119705 |
| 12 | MP0005083_abnormal_biliary_tract | 2.50316208 |
| 13 | MP0005332_abnormal_amino_acid | 2.40193577 |
| 14 | MP0004233_abnormal_muscle_weight | 2.39273652 |
| 15 | MP0006036_abnormal_mitochondrial_physio | 2.26472961 |
| 16 | MP0004145_abnormal_muscle_electrophysio | 2.26325955 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.23233113 |
| 18 | MP0001873_stomach_inflammation | 2.21852394 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.10601006 |
| 20 | MP0001661_extended_life_span | 2.09050144 |
| 21 | MP0002876_abnormal_thyroid_physiology | 2.08086023 |
| 22 | MP0003186_abnormal_redox_activity | 2.07324261 |
| 23 | MP0000609_abnormal_liver_physiology | 2.07095003 |
| 24 | MP0003786_premature_aging | 2.03178536 |
| 25 | MP0005319_abnormal_enzyme/_coenzyme | 1.98439056 |
| 26 | MP0003195_calcinosis | 1.93513173 |
| 27 | MP0005167_abnormal_blood-brain_barrier | 1.87078197 |
| 28 | MP0002118_abnormal_lipid_homeostasis | 1.81277293 |
| 29 | MP0002163_abnormal_gland_morphology | 1.80825177 |
| 30 | MP0000678_abnormal_parathyroid_gland | 1.75264121 |
| 31 | MP0001764_abnormal_homeostasis | 1.74050852 |
| 32 | MP0006035_abnormal_mitochondrial_morpho | 1.69889617 |
| 33 | MP0004019_abnormal_vitamin_homeostasis | 1.69183167 |
| 34 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.65950272 |
| 35 | MP0003172_abnormal_lysosome_physiology | 1.59825957 |
| 36 | MP0009643_abnormal_urine_homeostasis | 1.55026376 |
| 37 | MP0003868_abnormal_feces_composition | 1.52448324 |
| 38 | MP0005636_abnormal_mineral_homeostasis | 1.52443816 |
| 39 | MP0003950_abnormal_plasma_membrane | 1.43446199 |
| 40 | MP0002160_abnormal_reproductive_system | 1.43077425 |
| 41 | MP0003724_increased_susceptibility_to | 1.40680742 |
| 42 | MP0001986_abnormal_taste_sensitivity | 1.40304772 |
| 43 | MP0003959_abnormal_lean_body | 1.36226585 |
| 44 | MP0008995_early_reproductive_senescence | 1.33972417 |
| 45 | MP0005551_abnormal_eye_electrophysiolog | 1.33522468 |
| 46 | MP0000003_abnormal_adipose_tissue | 1.29852389 |
| 47 | MP0004130_abnormal_muscle_cell | 1.29150121 |
| 48 | * MP0000598_abnormal_liver_morphology | 1.28397665 |
| 49 | MP0005646_abnormal_pituitary_gland | 1.27996074 |
| 50 | MP0008058_abnormal_DNA_repair | 1.27345806 |
| 51 | MP0000015_abnormal_ear_pigmentation | 1.24152327 |
| 52 | MP0008469_abnormal_protein_level | 1.23424968 |
| 53 | MP0002396_abnormal_hematopoietic_system | 1.23192435 |
| 54 | MP0005451_abnormal_body_composition | 1.21961266 |
| 55 | MP0000681_abnormal_thyroid_gland | 1.21490167 |
| 56 | MP0005670_abnormal_white_adipose | 1.20908888 |
| 57 | MP0000372_irregular_coat_pigmentation | 1.20817205 |
| 58 | MP0002148_abnormal_hypersensitivity_rea | 1.20511598 |
| 59 | MP0002138_abnormal_hepatobiliary_system | 1.17658585 |
| 60 | MP0001853_heart_inflammation | 1.16988196 |
| 61 | MP0002332_abnormal_exercise_endurance | 1.14420496 |
| 62 | MP0002837_dystrophic_cardiac_calcinosis | 1.14034799 |
| 63 | MP0005464_abnormal_platelet_physiology | 1.14033391 |
| 64 | MP0006054_spinal_hemorrhage | 1.12351087 |
| 65 | MP0009697_abnormal_copulation | 1.10206011 |
| 66 | MP0009764_decreased_sensitivity_to | 1.10131583 |
| 67 | MP0002132_abnormal_respiratory_system | 1.09785135 |
| 68 | MP0009763_increased_sensitivity_to | 1.07535113 |
| 69 | MP0005397_hematopoietic_system_phenotyp | 1.04755801 |
| 70 | MP0001545_abnormal_hematopoietic_system | 1.04755801 |
| 71 | MP0002971_abnormal_brown_adipose | 1.03671128 |
| 72 | MP0005389_reproductive_system_phenotype | 1.03468985 |
| 73 | MP0004858_abnormal_nervous_system | 1.01686886 |
| 74 | MP0003011_delayed_dark_adaptation | 0.97970070 |
| 75 | MP0000750_abnormal_muscle_regeneration | 0.97864940 |
| 76 | MP0005410_abnormal_fertilization | 0.97622068 |
| 77 | MP0000604_amyloidosis | 0.95945690 |
| 78 | MP0005266_abnormal_metabolism | 0.94682053 |
| 79 | MP0005376_homeostasis/metabolism_phenot | 0.94166537 |
| 80 | MP0000013_abnormal_adipose_tissue | 0.92270708 |
| 81 | MP0003693_abnormal_embryo_hatching | 0.92245120 |
| 82 | MP0008961_abnormal_basal_metabolism | 0.92068051 |
| 83 | MP0002693_abnormal_pancreas_physiology | 0.91950977 |
| 84 | MP0009642_abnormal_blood_homeostasis | 0.91832954 |
| 85 | MP0001968_abnormal_touch/_nociception | 0.90719123 |
| 86 | MP0009333_abnormal_splenocyte_physiolog | 0.90614950 |
| 87 | MP0005535_abnormal_body_temperature | 0.90595072 |
| 88 | MP0005058_abnormal_lysosome_morphology | 0.88264868 |
| 89 | MP0003436_decreased_susceptibility_to | 0.87054644 |
| 90 | MP0001664_abnormal_digestion | 0.85316429 |
| 91 | MP0005666_abnormal_adipose_tissue | 0.85227027 |
| 92 | MP0000685_abnormal_immune_system | 0.84277333 |
| 93 | MP0003111_abnormal_nucleus_morphology | 0.83836397 |
| 94 | MP0005379_endocrine/exocrine_gland_phen | 0.83822645 |
| 95 | MP0001929_abnormal_gametogenesis | 0.83672379 |
| 96 | MP0003718_maternal_effect | 0.83197041 |
| 97 | MP0004043_abnormal_pH_regulation | 0.82827677 |
| 98 | MP0009785_altered_susceptibility_to | 0.81296951 |
| 99 | MP0002078_abnormal_glucose_homeostasis | 0.81275037 |
| 100 | MP0000490_abnormal_crypts_of | 0.81205155 |
| 101 | MP0009765_abnormal_xenobiotic_induced | 0.81069097 |
| 102 | MP0002210_abnormal_sex_determination | 0.79525359 |
| 103 | MP0005671_abnormal_response_to | 0.77995752 |
| 104 | MP0005334_abnormal_fat_pad | 0.77964646 |
| 105 | MP0005448_abnormal_energy_balance | 0.77962762 |
| 106 | MP0003646_muscle_fatigue | 0.77678843 |
| 107 | MP0000749_muscle_degeneration | 0.76929503 |
| 108 | MP0002970_abnormal_white_adipose | 0.75895693 |
| 109 | MP0010368_abnormal_lymphatic_system | 0.75775262 |
| 110 | MP0005330_cardiomyopathy | 0.75203640 |
| 111 | MP0001835_abnormal_antigen_presentation | 0.73843232 |
| 112 | MP0003698_abnormal_male_reproductive | 0.73526990 |
| 113 | MP0002723_abnormal_immune_serum | 0.72821397 |
| 114 | MP0004133_heterotaxia | 0.72769707 |
| 115 | MP0004215_abnormal_myocardial_fiber | 0.72586427 |
| 116 | MP0008775_abnormal_heart_ventricle | 0.72351712 |
| 117 | MP0003045_fibrosis | 0.72234973 |
| 118 | MP0001756_abnormal_urination | 0.72071800 |
| 119 | MP0000689_abnormal_spleen_morphology | 0.71879277 |
| 120 | MP0001145_abnormal_male_reproductive | 0.71557542 |
| 121 | MP0001502_abnormal_circadian_rhythm | 0.71407649 |
| 122 | MP0005310_abnormal_salivary_gland | 0.71215652 |
| 123 | MP0002168_other_aberrant_phenotype | 0.70891621 |
| 124 | MP0010094_abnormal_chromosome_stability | 0.70836419 |
| 125 | MP0000733_abnormal_muscle_development | 0.70355574 |
| 126 | MP0001905_abnormal_dopamine_level | 0.68899477 |
| 127 | MP0005220_abnormal_exocrine_pancreas | 0.68543337 |
| 128 | MP0001845_abnormal_inflammatory_respons | 0.67162772 |
| 129 | MP0002269_muscular_atrophy | 0.66732503 |
| 130 | MP0002722_abnormal_immune_system | 0.65512862 |
| 131 | MP0003705_abnormal_hypodermis_morpholog | 0.65162633 |
| 132 | MP0002136_abnormal_kidney_physiology | 0.64883661 |
| 133 | MP0005025_abnormal_response_to | 0.64798095 |
| 134 | MP0003221_abnormal_cardiomyocyte_apopto | 0.60038974 |
| 135 | MP0005647_abnormal_sex_gland | 0.59663853 |
| 136 | MP0008873_increased_physiological_sensi | 0.59548021 |
| 137 | MP0002419_abnormal_innate_immunity | 0.57760979 |
| 138 | MP0000465_gastrointestinal_hemorrhage | 0.57232303 |
| 139 | MP0003329_amyloid_beta_deposits | 0.56633491 |
| 140 | * MP0002429_abnormal_blood_cell | 0.56611151 |
| 141 | MP0002254_reproductive_system_inflammat | 0.55947882 |
| 142 | MP0002398_abnormal_bone_marrow | 0.55852961 |
| 143 | MP0005084_abnormal_gallbladder_morpholo | 0.54615573 |
| 144 | MP0000358_abnormal_cell_content/ | 0.54112532 |
| 145 | MP0008872_abnormal_physiological_respon | 0.53527551 |
| 146 | MP0010155_abnormal_intestine_physiology | 0.51693344 |
| 147 | MP0000747_muscle_weakness | 0.48481392 |
| 148 | MP0004084_abnormal_cardiac_muscle | 0.48405234 |
| 149 | MP0000343_altered_response_to | 0.47155583 |
| 150 | MP0004957_abnormal_blastocyst_morpholog | 0.46884012 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 6.50290859 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.21235805 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 4.48012449 |
| 4 | Deep venous thrombosis (HP:0002625) | 4.42278548 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.38728875 |
| 6 | Xanthomatosis (HP:0000991) | 4.17629459 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 4.16070117 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 4.14982018 |
| 9 | Poikilocytosis (HP:0004447) | 4.13357051 |
| 10 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.09354221 |
| 11 | Hyperammonemia (HP:0001987) | 3.97167520 |
| 12 | Hypochromic microcytic anemia (HP:0004840) | 3.90010692 |
| 13 | Hyperbilirubinemia (HP:0002904) | 3.88555434 |
| 14 | Hyperthyroidism (HP:0000836) | 3.86356370 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 3.79283275 |
| 16 | Hypoglycemic coma (HP:0001325) | 3.72621552 |
| 17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.71205186 |
| 18 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.69927207 |
| 19 | Hyperglycinuria (HP:0003108) | 3.66250652 |
| 20 | Ketosis (HP:0001946) | 3.59099951 |
| 21 | Ragged-red muscle fibers (HP:0003200) | 3.58959671 |
| 22 | Acanthocytosis (HP:0001927) | 3.54106954 |
| 23 | Reduced antithrombin III activity (HP:0001976) | 3.50959011 |
| 24 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.42126263 |
| 25 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.42126263 |
| 26 | Abnormal protein glycosylation (HP:0012346) | 3.39908907 |
| 27 | Abnormal glycosylation (HP:0012345) | 3.39908907 |
| 28 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.39908907 |
| 29 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.39908907 |
| 30 | Abnormality of methionine metabolism (HP:0010901) | 3.38654252 |
| 31 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.34596790 |
| 32 | Dicarboxylic aciduria (HP:0003215) | 3.34596790 |
| 33 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.33355803 |
| 34 | Abnormality of glycine metabolism (HP:0010895) | 3.33355803 |
| 35 | Hyperglycinemia (HP:0002154) | 3.30387386 |
| 36 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.26448614 |
| 37 | Hypolipoproteinemia (HP:0010981) | 3.25976118 |
| 38 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.21946452 |
| 39 | Cholelithiasis (HP:0001081) | 3.18302087 |
| 40 | Reticulocytosis (HP:0001923) | 3.15252638 |
| 41 | Joint hemorrhage (HP:0005261) | 3.14704835 |
| 42 | Increased cerebral lipofuscin (HP:0011813) | 3.11564987 |
| 43 | Clumsiness (HP:0002312) | 3.09399015 |
| 44 | Protruding tongue (HP:0010808) | 3.05532952 |
| 45 | Abnormal gallbladder morphology (HP:0012437) | 3.01680070 |
| 46 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.01235788 |
| 47 | Thoracic kyphosis (HP:0002942) | 3.01094065 |
| 48 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.00623533 |
| 49 | Abnormality of the common coagulation pathway (HP:0010990) | 2.98805042 |
| 50 | J-shaped sella turcica (HP:0002680) | 2.96508483 |
| 51 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.96436800 |
| 52 | Metabolic acidosis (HP:0001942) | 2.94381677 |
| 53 | Hypoalphalipoproteinemia (HP:0003233) | 2.93311524 |
| 54 | Truncus arteriosus (HP:0001660) | 2.93110751 |
| 55 | Ketoacidosis (HP:0001993) | 2.92738143 |
| 56 | Microretrognathia (HP:0000308) | 2.92394435 |
| 57 | Complement deficiency (HP:0004431) | 2.91853122 |
| 58 | Cerebral edema (HP:0002181) | 2.90886870 |
| 59 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.90159415 |
| 60 | Abnormality of serum amino acid levels (HP:0003112) | 2.87407173 |
| 61 | Hepatic necrosis (HP:0002605) | 2.86190667 |
| 62 | Congenital stationary night blindness (HP:0007642) | 2.82728985 |
| 63 | Abnormality of the intrinsic pathway (HP:0010989) | 2.82699660 |
| 64 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.77623046 |
| 65 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.77623046 |
| 66 | Abnormality of glycolipid metabolism (HP:0010969) | 2.77623046 |
| 67 | Type II lissencephaly (HP:0007260) | 2.75290508 |
| 68 | Hepatocellular carcinoma (HP:0001402) | 2.74174182 |
| 69 | Lethargy (HP:0001254) | 2.73451133 |
| 70 | Type I transferrin isoform profile (HP:0003642) | 2.72710694 |
| 71 | Generalized aminoaciduria (HP:0002909) | 2.69983163 |
| 72 | Nausea (HP:0002018) | 2.69438289 |
| 73 | Hypertensive crisis (HP:0100735) | 2.67797252 |
| 74 | Hypercholesterolemia (HP:0003124) | 2.59371367 |
| 75 | Abnormality of iron homeostasis (HP:0011031) | 2.57433030 |
| 76 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.56502525 |
| 77 | Microcytic anemia (HP:0001935) | 2.54297002 |
| 78 | Large for gestational age (HP:0001520) | 2.52999222 |
| 79 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.51399065 |
| 80 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.50987007 |
| 81 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.50518533 |
| 82 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.50518533 |
| 83 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.50518533 |
| 84 | Abnormality of nucleobase metabolism (HP:0010932) | 2.48977022 |
| 85 | Delayed CNS myelination (HP:0002188) | 2.47383802 |
| 86 | Testicular atrophy (HP:0000029) | 2.47348924 |
| 87 | Stridor (HP:0010307) | 2.45596243 |
| 88 | Vomiting (HP:0002013) | 2.45449573 |
| 89 | Increased muscle lipid content (HP:0009058) | 2.45320506 |
| 90 | Cholecystitis (HP:0001082) | 2.41339516 |
| 91 | Abnormal gallbladder physiology (HP:0012438) | 2.41339516 |
| 92 | Lactic acidosis (HP:0003128) | 2.40493207 |
| 93 | Increased serum ferritin (HP:0003281) | 2.39307381 |
| 94 | Abnormality of the renal cortex (HP:0011035) | 2.39164122 |
| 95 | Severe visual impairment (HP:0001141) | 2.37824684 |
| 96 | Fat malabsorption (HP:0002630) | 2.37809034 |
| 97 | Acute encephalopathy (HP:0006846) | 2.37796164 |
| 98 | Squamous cell carcinoma (HP:0002860) | 2.34596248 |
| 99 | Abnormality of reticulocytes (HP:0004312) | 2.32125740 |
| 100 | Nonimmune hydrops fetalis (HP:0001790) | 2.31202996 |
| 101 | Opisthotonus (HP:0002179) | 2.31166768 |
| 102 | Epidermoid cyst (HP:0200040) | 2.30074064 |
| 103 | Hepatocellular necrosis (HP:0001404) | 2.29578292 |
| 104 | Myoglobinuria (HP:0002913) | 2.28216720 |
| 105 | Facial diplegia (HP:0001349) | 2.26612621 |
| 106 | Conjugated hyperbilirubinemia (HP:0002908) | 2.25752366 |
| 107 | Abnormal number of erythroid precursors (HP:0012131) | 2.24101802 |
| 108 | Abnormality of the gallbladder (HP:0005264) | 2.23359756 |
| 109 | Pendular nystagmus (HP:0012043) | 2.23327606 |
| 110 | Abnormality of T cell physiology (HP:0011840) | 2.22933116 |
| 111 | Abnormality of purine metabolism (HP:0004352) | 2.22847639 |
| 112 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.22770760 |
| 113 | Abnormality of alanine metabolism (HP:0010916) | 2.22770760 |
| 114 | Hyperalaninemia (HP:0003348) | 2.22770760 |
| 115 | Polycythemia (HP:0001901) | 2.21233879 |
| 116 | Irritability (HP:0000737) | 2.20167698 |
| 117 | Multiple enchondromatosis (HP:0005701) | 2.19078840 |
| 118 | Proximal tubulopathy (HP:0000114) | 2.18673554 |
| 119 | Abnormality of the thoracic spine (HP:0100711) | 2.16117513 |
| 120 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.15259178 |
| 121 | Mucopolysacchariduria (HP:0008155) | 2.15259178 |
| 122 | Brushfield spots (HP:0001088) | 2.15099732 |
| 123 | Self-mutilation (HP:0000742) | 2.13787048 |
| 124 | Gout (HP:0001997) | 2.13654741 |
| 125 | Late onset (HP:0003584) | 2.13603917 |
| 126 | Progressive microcephaly (HP:0000253) | 2.13277752 |
| 127 | Rhabdomyolysis (HP:0003201) | 2.09236625 |
| 128 | Redundant skin (HP:0001582) | 2.09080413 |
| 129 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.08939901 |
| 130 | Increased intramyocellular lipid droplets (HP:0012240) | 2.08758787 |
| 131 | Bulbous nose (HP:0000414) | 2.07265444 |
| 132 | Severe muscular hypotonia (HP:0006829) | 2.06563608 |
| 133 | Mitochondrial inheritance (HP:0001427) | 2.06441947 |
| 134 | Abnormality of complement system (HP:0005339) | 2.05665729 |
| 135 | Abnormal cartilage morphology (HP:0002763) | 2.04235663 |
| 136 | Hypochromic anemia (HP:0001931) | 2.03371254 |
| 137 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.02393479 |
| 138 | Increased serum lactate (HP:0002151) | 1.99056965 |
| 139 | Increased CSF lactate (HP:0002490) | 1.97726268 |
| 140 | Hypoplasia of the pons (HP:0012110) | 1.97709479 |
| 141 | Renal cortical cysts (HP:0000803) | 1.95861593 |
| 142 | Cerebral palsy (HP:0100021) | 1.95442860 |
| 143 | Attenuation of retinal blood vessels (HP:0007843) | 1.93794881 |
| 144 | Albinism (HP:0001022) | 1.93278987 |
| 145 | Birth length less than 3rd percentile (HP:0003561) | 1.92124138 |
| 146 | Pancreatic cysts (HP:0001737) | 1.92115781 |
| 147 | Dysostosis multiplex (HP:0000943) | 1.92082099 |
| 148 | Abnormality of the pons (HP:0007361) | 1.92002273 |
| 149 | Elevated hepatic transaminases (HP:0002910) | 1.91513662 |
| 150 | Concave nail (HP:0001598) | 1.91299782 |
| 151 | Seborrheic dermatitis (HP:0001051) | 1.90476156 |
| 152 | Epistaxis (HP:0000421) | 1.90338311 |
| 153 | Glycosuria (HP:0003076) | 1.89870223 |
| 154 | Abnormality of urine glucose concentration (HP:0011016) | 1.89870223 |
| 155 | Ileus (HP:0002595) | 1.89477455 |
| 156 | Pancreatitis (HP:0001733) | 1.89112635 |
| 157 | Acute necrotizing encephalopathy (HP:0006965) | 1.88730158 |
| 158 | 3-Methylglutaconic aciduria (HP:0003535) | 1.86652058 |
| 159 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.81156303 |
| 160 | Chronic obstructive pulmonary disease (HP:0006510) | 1.80720755 |
| 161 | Obstructive lung disease (HP:0006536) | 1.80720755 |
| 162 | Abnormality of the lumbar spine (HP:0100712) | 1.80257446 |
| 163 | Visual hallucinations (HP:0002367) | 1.79173733 |
| 164 | Slender long bone (HP:0003100) | 1.79014869 |
| 165 | Pustule (HP:0200039) | 1.78868770 |
| 166 | Tinnitus (HP:0000360) | 1.78588306 |
| 167 | Cerebellar dysplasia (HP:0007033) | 1.78396006 |
| 168 | Prolonged QT interval (HP:0001657) | 1.77616969 |
| 169 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.75172557 |
| 170 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.74562264 |
| 171 | Breast hypoplasia (HP:0003187) | 1.74127838 |
| 172 | Mesangial abnormality (HP:0001966) | 1.71949218 |
| 173 | Cortical visual impairment (HP:0100704) | 1.69480966 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.42566838 |
| 2 | ERN1 | 3.69402727 |
| 3 | EIF2AK1 | 3.65361261 |
| 4 | NME2 | 3.31362115 |
| 5 | FLT3 | 3.13695027 |
| 6 | FRK | 3.02503623 |
| 7 | SIK1 | 2.89566973 |
| 8 | TRIB3 | 2.84593661 |
| 9 | PKN2 | 2.76458442 |
| 10 | STK16 | 2.49589135 |
| 11 | VRK2 | 2.23164933 |
| 12 | DAPK2 | 2.18531829 |
| 13 | IRAK4 | 2.12914508 |
| 14 | MAP2K3 | 2.02864094 |
| 15 | CAMK1D | 2.02524211 |
| 16 | MAP4K1 | 1.96511300 |
| 17 | SMG1 | 1.93655304 |
| 18 | KDR | 1.91166076 |
| 19 | CAMKK2 | 1.83241791 |
| 20 | TAOK3 | 1.78070481 |
| 21 | MAP3K11 | 1.75724515 |
| 22 | WNK4 | 1.74081960 |
| 23 | ADRBK2 | 1.71457399 |
| 24 | FGFR4 | 1.62820455 |
| 25 | MAPKAPK5 | 1.61471984 |
| 26 | TBK1 | 1.60986632 |
| 27 | MUSK | 1.59056712 |
| 28 | BUB1 | 1.57112865 |
| 29 | IRAK1 | 1.56104847 |
| 30 | PRKD3 | 1.49678077 |
| 31 | IRAK2 | 1.44239758 |
| 32 | ICK | 1.43248009 |
| 33 | KIT | 1.41343435 |
| 34 | TNK2 | 1.38039590 |
| 35 | GRK1 | 1.37039695 |
| 36 | MAPK11 | 1.36074951 |
| 37 | TXK | 1.35450091 |
| 38 | SCYL2 | 1.31910840 |
| 39 | CSF1R | 1.31714518 |
| 40 | WEE1 | 1.28542235 |
| 41 | PDK2 | 1.28371172 |
| 42 | TYK2 | 1.26332281 |
| 43 | BLK | 1.26270948 |
| 44 | DAPK1 | 1.23898699 |
| 45 | TIE1 | 1.23074139 |
| 46 | CDK4 | 1.19616815 |
| 47 | ZAP70 | 1.18184214 |
| 48 | MAP3K10 | 1.16785593 |
| 49 | CDK8 | 1.13134355 |
| 50 | EEF2K | 1.11790662 |
| 51 | GRK6 | 1.09092834 |
| 52 | BRSK2 | 1.08057165 |
| 53 | EIF2AK3 | 1.07860481 |
| 54 | IRAK3 | 1.06044213 |
| 55 | ABL2 | 1.05735339 |
| 56 | HIPK2 | 1.04421868 |
| 57 | NUAK1 | 1.02878670 |
| 58 | PINK1 | 1.01349672 |
| 59 | RIPK4 | 1.01249281 |
| 60 | TGFBR2 | 1.00908387 |
| 61 | IKBKE | 1.00805812 |
| 62 | RPS6KA5 | 1.00340403 |
| 63 | MAPK12 | 0.99543928 |
| 64 | RPS6KB2 | 0.98593786 |
| 65 | CCNB1 | 0.96943172 |
| 66 | NEK1 | 0.96388954 |
| 67 | RPS6KA6 | 0.96333284 |
| 68 | SYK | 0.95200372 |
| 69 | PIK3CG | 0.93337159 |
| 70 | VRK1 | 0.92402969 |
| 71 | TEC | 0.91480597 |
| 72 | PRKCI | 0.90924130 |
| 73 | DAPK3 | 0.90239484 |
| 74 | PDPK1 | 0.90101699 |
| 75 | TLK1 | 0.89888523 |
| 76 | MYLK | 0.89701877 |
| 77 | JAK2 | 0.88322558 |
| 78 | INSRR | 0.87619935 |
| 79 | PRKAA2 | 0.87458669 |
| 80 | PIM2 | 0.85894364 |
| 81 | PDK3 | 0.82899374 |
| 82 | PDK4 | 0.82899374 |
| 83 | EPHA2 | 0.82855150 |
| 84 | LRRK2 | 0.82530735 |
| 85 | CDK19 | 0.82421909 |
| 86 | BRSK1 | 0.82138903 |
| 87 | DYRK3 | 0.81456201 |
| 88 | BTK | 0.81015187 |
| 89 | MAP3K7 | 0.78102363 |
| 90 | BMPR1B | 0.77811188 |
| 91 | PRKD2 | 0.76586402 |
| 92 | TAF1 | 0.75131960 |
| 93 | CDK6 | 0.74939666 |
| 94 | MAPKAPK3 | 0.74430280 |
| 95 | PIM1 | 0.70849314 |
| 96 | JAK3 | 0.70721155 |
| 97 | RPS6KA4 | 0.69374275 |
| 98 | CAMK1G | 0.67998224 |
| 99 | PRKG2 | 0.67990697 |
| 100 | RPS6KL1 | 0.67961721 |
| 101 | RPS6KC1 | 0.67961721 |
| 102 | LYN | 0.65606807 |
| 103 | CHEK2 | 0.64726103 |
| 104 | STK24 | 0.64526717 |
| 105 | PTK2B | 0.63545994 |
| 106 | TTN | 0.63521465 |
| 107 | PHKG2 | 0.62178131 |
| 108 | PHKG1 | 0.62178131 |
| 109 | STK4 | 0.60927132 |
| 110 | MAPK4 | 0.59422299 |
| 111 | CAMKK1 | 0.58771208 |
| 112 | MAPK13 | 0.57017262 |
| 113 | RPS6KA2 | 0.56985750 |
| 114 | CDC7 | 0.56627025 |
| 115 | ZAK | 0.55090706 |
| 116 | TAOK2 | 0.54149629 |
| 117 | MAP3K8 | 0.53216684 |
| 118 | ILK | 0.52907872 |
| 119 | MAP2K1 | 0.52407530 |
| 120 | CHUK | 0.51425633 |
| 121 | AURKB | 0.51121297 |
| 122 | TRPM7 | 0.51079343 |
| 123 | SIK2 | 0.50529519 |
| 124 | DYRK1B | 0.49903985 |
| 125 | MAP3K14 | 0.49107337 |
| 126 | TGFBR1 | 0.49102365 |
| 127 | JAK1 | 0.48465573 |
| 128 | MAP2K6 | 0.48057654 |
| 129 | GRK5 | 0.47534795 |
| 130 | MAP3K3 | 0.46912703 |
| 131 | IKBKB | 0.45908658 |
| 132 | MAP3K1 | 0.44741058 |
| 133 | NEK2 | 0.44199831 |
| 134 | MARK3 | 0.43833121 |
| 135 | EPHB1 | 0.43811728 |
| 136 | CSNK1G3 | 0.43184545 |
| 137 | NEK9 | 0.42003153 |
| 138 | PRKACG | 0.41747046 |
| 139 | ACVR1B | 0.41580136 |
| 140 | CAMK4 | 0.41116463 |
| 141 | TAOK1 | 0.40854645 |
| 142 | MAP2K4 | 0.37641392 |
| 143 | MAP2K2 | 0.37061894 |
| 144 | NME1 | 0.36130763 |
| 145 | MAP3K5 | 0.33708625 |
| 146 | OBSCN | 0.33377635 |
| 147 | TTK | 0.31688135 |
| 148 | PDK1 | 0.31317321 |
| 149 | PRKAA1 | 0.29390323 |
| 150 | CSNK2A2 | 0.29275284 |
| 151 | CSNK2A1 | 0.28213786 |
| 152 | MAPK7 | 0.26763474 |
| 153 | CAMK1 | 0.25025496 |
| 154 | AURKA | 0.23407812 |
| 155 | PTK6 | 0.23259628 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.32018979 |
| 2 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.84250325 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.71467330 |
| 4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.71163248 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.63934483 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.61347567 |
| 7 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.60983833 |
| 8 | Homologous recombination_Homo sapiens_hsa03440 | 2.58550226 |
| 9 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.44391825 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.42412079 |
| 11 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.40624676 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.38442003 |
| 13 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.37473170 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.29905465 |
| 15 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.28326366 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.22803008 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.14018064 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.10376382 |
| 19 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.09127315 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.08068758 |
| 21 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.06842331 |
| 22 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.05096636 |
| 23 | Peroxisome_Homo sapiens_hsa04146 | 1.97997873 |
| 24 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.95909384 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.85475681 |
| 26 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.81839584 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.79659399 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.78506331 |
| 29 | Carbon metabolism_Homo sapiens_hsa01200 | 1.75825618 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.70967826 |
| 31 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.70368990 |
| 32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.69449175 |
| 33 | Sulfur relay system_Homo sapiens_hsa04122 | 1.69356949 |
| 34 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.66023375 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.63759594 |
| 36 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.63221133 |
| 37 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.56301780 |
| 38 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.53480168 |
| 39 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.50104699 |
| 40 | * Selenocompound metabolism_Homo sapiens_hsa00450 | 1.49251935 |
| 41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.42800820 |
| 42 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.41516371 |
| 43 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.35448624 |
| 44 | Histidine metabolism_Homo sapiens_hsa00340 | 1.31796816 |
| 45 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.31694596 |
| 46 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.29128162 |
| 47 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.29056752 |
| 48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.28432754 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27359265 |
| 50 | Lysosome_Homo sapiens_hsa04142 | 1.26512802 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 1.24335367 |
| 52 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.24238563 |
| 53 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.23348692 |
| 54 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.18805205 |
| 55 | Retinol metabolism_Homo sapiens_hsa00830 | 1.18427508 |
| 56 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.16891431 |
| 57 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.15341716 |
| 58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.15329602 |
| 59 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.13123285 |
| 60 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.12665391 |
| 61 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.11881036 |
| 62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.11151759 |
| 63 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.10048169 |
| 64 | DNA replication_Homo sapiens_hsa03030 | 1.07125213 |
| 65 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.05970870 |
| 66 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.04744110 |
| 67 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.04234321 |
| 68 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.01124820 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.00877737 |
| 70 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.99750124 |
| 71 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.93059020 |
| 72 | Bile secretion_Homo sapiens_hsa04976 | 0.92877507 |
| 73 | Ribosome_Homo sapiens_hsa03010 | 0.91891835 |
| 74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.85889165 |
| 75 | Phototransduction_Homo sapiens_hsa04744 | 0.84981777 |
| 76 | Proteasome_Homo sapiens_hsa03050 | 0.84284962 |
| 77 | * Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.83138387 |
| 78 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.80414074 |
| 79 | Bladder cancer_Homo sapiens_hsa05219 | 0.79385176 |
| 80 | Galactose metabolism_Homo sapiens_hsa00052 | 0.75925353 |
| 81 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.75657886 |
| 82 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.73382675 |
| 83 | Parkinsons disease_Homo sapiens_hsa05012 | 0.72213488 |
| 84 | Metabolic pathways_Homo sapiens_hsa01100 | 0.71852939 |
| 85 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.69633643 |
| 86 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.67288525 |
| 87 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61909047 |
| 88 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.58306526 |
| 89 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.58089159 |
| 90 | Lysine degradation_Homo sapiens_hsa00310 | 0.57953430 |
| 91 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.57567397 |
| 92 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.55776990 |
| 93 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.52215507 |
| 94 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.50692693 |
| 95 | Basal transcription factors_Homo sapiens_hsa03022 | 0.50641674 |
| 96 | Olfactory transduction_Homo sapiens_hsa04740 | 0.50177324 |
| 97 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.49744167 |
| 98 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.45082557 |
| 99 | Base excision repair_Homo sapiens_hsa03410 | 0.42300004 |
| 100 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.39556038 |
| 101 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.39304177 |
| 102 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37116745 |
| 103 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.36409471 |
| 104 | Mismatch repair_Homo sapiens_hsa03430 | 0.36134351 |
| 105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35010245 |
| 106 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.33863019 |
| 107 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.32164321 |
| 108 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.31490970 |
| 109 | Huntingtons disease_Homo sapiens_hsa05016 | 0.30139087 |
| 110 | Alzheimers disease_Homo sapiens_hsa05010 | 0.29901949 |
| 111 | Protein export_Homo sapiens_hsa03060 | 0.29840648 |
| 112 | Insulin resistance_Homo sapiens_hsa04931 | 0.24388397 |
| 113 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.23127175 |
| 114 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22105548 |
| 115 | RNA polymerase_Homo sapiens_hsa03020 | 0.18657180 |
| 116 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.18220341 |
| 117 | Purine metabolism_Homo sapiens_hsa00230 | 0.16797279 |
| 118 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.16791040 |
| 119 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.16323913 |
| 120 | Legionellosis_Homo sapiens_hsa05134 | 0.14811166 |
| 121 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.13986870 |
| 122 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.11794147 |
| 123 | Other glycan degradation_Homo sapiens_hsa00511 | 0.10975065 |
| 124 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.10891827 |
| 125 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10370499 |
| 126 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.09365147 |
| 127 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.08303229 |

